MedPath

Probiotic Beer to Enhance Gut Health and Immune System Function

Not Applicable
Completed
Conditions
Nutrition, Healthy
Inflammation
Interventions
Dietary Supplement: Moderate probiotic beer consumption
Dietary Supplement: Moderate normal beer consumption
Registration Number
NCT05401604
Lead Sponsor
National University of Singapore
Brief Summary

This study investigates the immunological and gut microbiome effects of moderate probiotic beer consumption.

Detailed Description

Studies have shown that moderate alcohol consumption and probiotics have each shown immunomodulatory anti-inflammatory effects. However, to our knowledge, the effect of adding a probiotic strain to a beer drink, together with moderate alcohol consumption, on immunity and gut microbiome has yet to be studied. The probiotic beer used in this study taps on this unexplored research area and may potentially serve as a more healthful option to consumers than normal beer in the future, given the vast popularity of this beverage and probiotics.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Ability to give informed consent.
  • 21 - 60 years of age (inclusive) at screening.
  • Healthy male, as determined by medical history, physical examination and laboratory results within normal reference range for the population or investigator site, or results with acceptable deviations that are judged to be not clinically significant by the investigator.
  • Race must be Chinese.
  • Willing to consume 1 beer can per day for 14 days.
  • Not on any regular medications (western/ traditional).
  • No family history of alcoholism.
Exclusion Criteria
  • Female.
  • A current smoker, have smoked, or is a user of tobacco products for the past 2 years.
  • History or presence of current lipid and cardiovascular disorders, respiratory, hepatic, renal, gastrointestinal, endocrine, lipid disorder, haematological, malignancy or neurological disorders capable of significantly altering the performance of the biomarker panel; or of interfering with the interpretation of data.
  • History of alcoholism, alcohol dependence, alcohol abuse, alcohol allergy and/or any other alcohol use disorders.
  • History of Type 1/ Type 2 diabetes and use of anti-diabetic medications in the past.
  • Regular use of medication that are known to have an effect on immune function.
  • Regular use of aspirin.
  • A naïve alcohol drinker.
  • Persons with known or ongoing psychiatric disorders or drug abuse within 3 years.
  • Active infection requiring systemic antiviral or antimicrobial therapy that will not be completed prior to first visit of the study.
  • Treatment with any investigational drug, or biological agent within one (1) month of screening or plans to enter into an investigational drug/ biological agent study during the duration of this study.
  • Significant change in weight (+/- 5%) during the past month.
  • Antibiotic use in the past 2 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Moderate probiotic beer consumptionModerate probiotic beer consumption1 can of 330ml (3.5-5% alcohol) probiotic beer. Ingredients: water, grains, raspberry puree, yeast, and lactic acid bacteria (Lactobacillus paracasei Lpc-37®, or Lactobacillus paracasei LAFTI®L26).
Moderate normal beer consumptionModerate normal beer consumption1 can of 330ml (3.5-5% alcohol) normal beer. Ingredients: water, grains, raspberry puree, and yeast.
Primary Outcome Measures
NameTimeMethod
Changes in inflammatory cytokine profile after moderate probiotic beer consumption.5 weeks

Changes in inflammatory cytokine profile (IFNg, TNFa, IL-1b, IL-2, IL-4, IL-6, IL-10, IL-12) in blood samples of individuals after moderate probiotic beer consumption, in comparison to moderate normal beer consumption.

Changes in gut microbiome profile after moderate probiotic beer consumption.5 weeks

Changes in gut microbiome profile from DNA sequencing in stool samples after moderate probiotic beer consumption, in comparison to moderate normal beer consumption.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National University of Singapore

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath